,
Nicholls, Stuart G. http://orcid.org/0000-0003-0485-9069
Carroll, Kelly
Zwarenstein, Merrick
Brehaut, Jamie C.
Weijer, Charles
Hey, Spencer P.
Goldstein, Cory E.
Graham, Ian D.
Grimshaw, Jeremy M.
McKenzie, Joanne E.
Fergusson, Dean A.
Taljaard, Monica
Funding for this research was provided by:
Canadian Institutes of Health Research (PJT-153045)
Article History
Received: 25 June 2019
Accepted: 8 November 2019
First Online: 23 December 2019
Ethics approval and consent to participate
: The study was reviewed and approved by the Ottawa Health Sciences Research Ethics Board (reference 20170435-01H) and all individuals provided informed consent to participate in the study.
: All authors have approved the manuscript for publication.
: CW receives consulting income from Eli Lilly and Company Canada. MZ has received reimbursement for conducting training in pragmatic trial design from National Cancer Institute, NIH; and Karolinska Institute, Stockholm, Sweden. The remaining authors declare that they have no competing interests.